Amfepramone: Difference between revisions
No edit summary |
→Legality: This drug is DEFINITELY available in the USA with a prescription |
||
Line 70: | Line 70: | ||
== Legality == |
== Legality == |
||
Amfepramone is classified as a [[Controlled Substances Act#Schedule IV controlled substances|Schedule IV]] [[controlled substance]] in the [[United States]]. It is also a Schedule IV controlled substance in Canada. In the UK Amfepramone is a class C drug <ref>{{ cite web | url = http://www.legislation.gov.uk/ukpga/1971/38/schedule/2 | work = Schedule 2 Controlled Drugs | title = Class C Drugs | publisher = UK Legislation }}</ref> and as a medicine, it is a Schedule 3 Controlled Drug which requires safe custody. |
Amfepramone is classified as a [[Controlled Substances Act#Schedule IV controlled substances|Schedule IV]] [[controlled substance]] in the [[United States]]. It is also a Schedule IV controlled substance in Canada. In the UK Amfepramone is a class C drug <ref>{{ cite web | url = http://www.legislation.gov.uk/ukpga/1971/38/schedule/2 | work = Schedule 2 Controlled Drugs | title = Class C Drugs | publisher = UK Legislation }}</ref> and as a medicine, it is a Schedule 3 Controlled Drug which requires safe custody. |
||
It's not US FDA approved. |
|||
==Chemistry== |
==Chemistry== |
Revision as of 16:30, 1 November 2015
![]() | |
Clinical data | |
---|---|
Trade names | Tenuate |
Other names | Diethylpropion |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682037 |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 4-6 hours (metabolites)[1] |
Excretion | Urine (>75%)[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.001.836 |
Chemical and physical data | |
Formula | C13H19NO |
Molar mass | 205.30 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Amfepramone (INN)[note 1] is a stimulant drug of the phenethylamine, amphetamine, and cathinone classes that is used as an appetite suppressant.[2][3] It is used in the short-term management of obesity, along with dietary and lifestyle changes.[2] Amfepramone is most closely chemically related to the antidepressant and smoking cessation aid bupropion (previously called amfebutamone), which has also been developed as a weight-loss medicine when in a combination product with naltrexone.[4]
Pharmacology
Amfepramone itself lacks any affinity for the monoamine transporters and instead functions as a prodrug to ethcathinone.[5] Ethcathinone (and therefore amfepramone as well) is a very weak dopaminergic and serotonergic, and is approximately 10x and 20x stronger on norepinephrine in comparison, respectively.[5] As a result, ethcathinone and amfepramone can essentially be considered a member of the class of drugs known as norepinephrine releasing agents (NRAs).
Abuse
Amfepramone is believed to have relatively low abuse potential.[6][7][8][9] but recently there have been reports of teens and adults in the UK abusing this drug, known as "tombstones" to the abusers.
Legality
Amfepramone is classified as a Schedule IV controlled substance in the United States. It is also a Schedule IV controlled substance in Canada. In the UK Amfepramone is a class C drug [10] and as a medicine, it is a Schedule 3 Controlled Drug which requires safe custody.
Chemistry
- Propiophenone is brominated to produce α-bromopropiophenone.
- This is reacted with diethylamine to yield the product, diethylpropion.[11][12]
See also
Notes
- ^ Another medically-utilized name is diethylpropion (BAN and AAN). Chemical names include: α-methyl-β-keto-N,N-diethylphenethylamine, N,N-diethyl-β-ketoamphetamine and N,N-diethylcathinone. Brand names include: Anorex, Linea, Nobesine, Prefamone, Regenon, Tepanil and Tenuate.
References
- ^ a b "SPC-DOC_PL 16133-0001" (PDF). Medicines Healthcare products Regulatory Agency. Essential Nutrition Ltd. 18 November 2011. Retrieved 18 July 2014.
- ^ a b Brayfield, A, ed. (30 January 2013). "Diethylpropion Hydrochloride". Martindale: The Complete Drug Reference. London, UK: Pharmaceutical Press. Retrieved 18 July 2014.
- ^ "TGA Approved Terminology for Medicines, Section 1 – Chemical Substances" (Document). Therapeutic Goods Administration, Department of Health and Ageing, Australian Government. July 1999. p. 42.
{{cite document}}
: Unknown parameter|format=
ignored (help); Unknown parameter|url=
ignored (help) - ^ Arias, HR; Santamaría, A; Ali, SF (2009). "Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion". International Review of Neurobiology. 88: 223–55. doi:10.1016/S0074-7742(09)88009-4. PMID 19897080.
- ^ a b Rothman, RB; Baumann, MH (2006). "Therapeutic Potential of Monoamine Transporter Substrates". Current Topics in Medicinal Chemistry. 6 (17): 1845–1859. doi:10.2174/156802606778249766. PMID 17017961.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Cohen, S (1977). "Diethylpropion (Tenuate): An Infrequently Abused Anorectic". Psychosomatics. 18 (1): 28–33. doi:10.1016/S0033-3182(77)71101-6. PMID 850721.
- ^ Jasinski, DR; Krishnan, S (June 2009). "Abuse Liability and Safety of Oral Lisdexamfetamine Dimesylate in Individuals with a History of Stimulant Abuse". Journal of Psychopharmacology. 23 (4): 419–427. doi:10.1177/0269881109103113. PMID 19329547.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ "Tepanil (diethylpropion hydrochloride) tablet, extended release". Dailymed. National Institutes of Health.
- ^ Caplan, J (May 1963). "Habituation to Diethylpropion (Tenuate)". Canadian Medical Association Journal. 88: 943–944. PMC 1921278. PMID 14018413.
- ^ "Class C Drugs". Schedule 2 Controlled Drugs. UK Legislation.
- ^ US patent 3001910, "Anorexigenic Propiophenones", issued 1961-09-26, assigned to Temmler-Werke
- ^ Hyde, J. F.; Browning, E.; Adams, R. (1928). "Synthetic Homologs of d,l-Ephedrine". Journal of the American Chemical Society. 50 (8): 2287–2292. doi:10.1021/ja01395a032.